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Objective. Altered calcium homeostasis has been linked to increased intima-media thickness (IMT) and plaques. We aimed
to investigate whether serum 25-hydroxyvitamin D (25(OH)D) and serum calcium are associated with IMT and plaques in
nonsmoking population.Methods. Ultrasound of the right carotid arterywith themeasurements of IMT and plaqueswas performed
in 4194 nonsmoking subjects with available measurements of serum 25(OH)D and total calcium. Linear regression was applied to
study the linear relationships between variables. Multinomial logistic regression was used to evaluate predictors of increased IMT
and total plaque area (TPA), adjusted for age, body mass index, systolic blood pressure, and total cholesterol. Results. There was no
significant linear relationship between mean IMT, TPA, and either serum 25(OH)D or total serum calcium. One SD increase in
serum 25(OH)D was independently associated with increased odds of being in the highest quartile of IMT in men (OR 1.30, 95%
CI 1.12, 1.51). In women, 1 SD increase in serum 25(OH)D was independently associated with increased risk of being in the upper
tertile of TPA (OR 1.15, 95% CI 1.01, 1.33). Conclusions. Impaired calcium homeostasis has no consistent association with mean IMT
and TPA; however, increased serum 25(OH)D may predict subclinical atherosclerosis in nonsmokers.
1. Introduction
Carotid atherosclerosis is a progressive, multifactorial artery
disease, associated with high risks of morbidity andmortality
[1]. Subclinical carotid atherosclerosis is an acknowledged
challenge in primary stroke prevention [2]. Several underly-
ing environmental and modifiable factors, such as increased,
elevated systolic blood pressure (SBP), dyslipidemia, smok-
ing, and increased body mass index (BMI), play a significant
role in the progression of the atherogenic process [2]. Carotid
intima-media thickness (IMT) and plaque assessment by cer-
vical ultrasonography is a noninvasive, feasible, and accurate
method for detecting asymptomatic carotid atherosclerosis
[3]. It is also largely used for risk assessment in primary
prevention and in clinical trials as a surrogate endpoint for
cardiovascular and cerebral events [3]. Both IMT and total
plaque area (TPA) are associated with an increased risk
of ischemic stroke and coronary heart disease [3, 4]. It is
well established that the presence of carotid plaques repre-
sents advanced carotid atherosclerosis, often symptomatic,
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whereas IMT can be assessed in the absence of focal plaques
and symptoms [4, 5].
Altered calcium homeostasis, including vitamin D defi-
ciency, was recently associated with subclinical atherosclero-
sis [6] and low bone mineral density, which may predict risk
of stroke in women [7]. Though the main role of vitamin D
is the maintenance of mineral homeostasis and bone health
[8], recent large epidemiological studies have linked vitamin
D insufficiency to cardiovascular diseases, infections, and
even cancer [9–11]. Furthermore, low serum levels of 25-
hydroxyvitamin D (25(OH)D), the metabolite which is used
to assess a subject’s vitamin D status [12], are associated with
insulin resistance and metabolic syndrome [13, 14].
In the fourth survey of population-based Tromsø Study
in North Norway in 1994-1995, ultrasonography of the right
carotid artery and measurements of serum 25(OH)D and
total calcium were performed in a large subgroup, thus
allowing us to evaluate the potential relationship between
vitamin D status and both IMT and plaques.
2. Materials and Methods
2.1. Study Population. The Tromsø Study is a population-
based health survey, which was performed for the first time
in 1974 [15]. In the fourth survey of the Tromsø Study in
1994-1995, all men and women at age >24 years and living
in the municipality of Tromsø, North Norway, were invited
to participate. All subjects aged 55–74 years and random
5–10% samples of the other age groups were invited to a
second visit for amore extensive examinationwhich included
carotid ultrasound examination. Height and weight were
measured while the subjects wore light clothing and no
shoes. Body mass index (BMI) was defined as weight (kg)
divided by squared height (m2). Blood pressure and heart
rate were measured with an automatic device (Dinamap Vital
Signs Monitor 1846, Critikon Inc., Tampa, FL) and the mean
measurement of the second and the third measurements was
used in the statistical analysis. Blood samples were drawn in a
nonfasting state. Serum levels of 25(OH)D were analysed by
immunometry (electrochemiluminescence immunoassay),
using an automated clinical chemistry analyser (Modular
E170; Roche Diagnostics). According to the manufacturer,
the assay has a total coefficient of variation (CV) ≤7.8% as
judged at any of the three different concentrations (48.6, 73.8
and 177.0 nmol/L). Analytical sensitivity was 10 nmol/L and a
population-based reference range was 27.7–107.0 nmol/L for
adults as provided by the manufacturer. This analysis has
been approved by the Norwegian Accreditation Authority.
With this assay, it has recently been described that smokers
had 15–20% higher serum 25(OH)D than that of nonsmokers
[16]. However, the same pattern was not observed when
using other immunological and liquid-chromatographymass
spectrometry methods [16]. This discrepancy is still lacking
an explanation, and to avoid this bias, we have included
only nonsmokers in our study cohort. Serum total cholesterol
was analyzed by enzymatic colorimetric methods (CHOD-
PAP; Boehringer Mannheim). The determination of serum
calcium was performed on Hitachi 917 with reagents from
Boehringer Mannheim, reference range 2.20–2.60mmol/L
and CV is 2%. Lipid levels were measured twice with an
interval of 4 to 12 weeks, and the averages of these values were
used in the analysis.
2.2. Questionnaires. Information about smoking habits,
angina pectoris, previous myocardial infarction, and stroke
was collected from self-administered questionnaires. Smok-
ers were classified as current smokers or nonsmokers.
2.3. Measurements of IMT and Carotid Plaques. Carotid
ultrasound was performed as previously described in detail
[4]. In short, the examination of the right carotid artery
was performed in the supine position with a high-resolution
Acuson 128XP/10 ART upgraded scanner (Mountain View,
CA) equippedwith a linear transducer with 7MHz in Bmode
and 5MHz in pulsed-Doppler mode. IMT was measured in
10mm segments in three locations of the carotid artery: the
near and farwall of the common carotid artery (CCA) and the
farwall (FW) of the bifurcation.The loss of parallel configura-
tion of the near and far walls of the CCA served as a reference
point for the start of the carotid bifurcation. Three frozen
images from each segment were stored in high-resolution
videotapes. The ultrasonic images were analyzed offline with
a computerized technique for automatic ultrasonic image
analysis. The average IMT from three preselected images was
calculated for each location. Plaques were included in the
measurements of IMT if theywere located in areas predefined
for IMT registration. The reproducibility of the ultrasound
measurements was acceptable [17].
A plaque was defined as a localized protrusion into the
vessel lumen with thickening of the vessel wall of >50%
compared to the adjacent IMT. Frozen images were recorded
for each plaque and digitalized for the further examination.
Six locations of the carotid artery were examined for plaque
presence, the far and near walls of the CCA, the bifurcation
(bulb), and the ICA. The area of each plaque was outlined
manually with automatic calculation of plaque area. TPA was
calculated as the sum of plaque areas in all six locations.
2.4. Statistics. Continuous variables are presented as mean ±
standard deviation (SD), unless otherwise stated. All contin-
uous variables were standardized prior to inclusion in the
linear and logistic regression analyses. The distribution of
all variables was determined by measuring skewness and
kurtosis and assessments of normal Q-Q plots of standard-
ized variables. TPA was square root transformed to obtain
normal distribution. Analyses of the scatter plots and linear
regression model were used to assess the relation between
serum25(OH)D and themeasurements of carotid atheroscle-
rosis (mean IMT, TPA, and plaques). Strata of mean IMT
(quartiles) and TPA (no plaques or tertiles of TPA) were
created. A multinomial logistic regression model was applied
to assess the effect of serum 25(OH)D and total calcium
across strata of mean IMT (using first quartile as a reference)
and TPA (using no plaques as a reference group). Continuous
variables: (age, BMI, SBP, total cholesterol) and categorical
variable season (summer, fall, winter and spring) of vitaminD
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Age, years 60.5 ± 9.7 61.8 ± 9.8
History of cardiovascular
disease, 𝑛 (%)
Heart attack 205 (10.2) 70 (3.2)
Angina 237 (11.8) 192 (8.7)
Stroke 64 (3.2) 56 (2.5)
BMI, kg/m2 26.5 ± 3.2 26.7 ± 4.5
Serum 25(OH)D, nmol L−1 54.8 ± 16.6 50.0 ± 16.7∗
Total cholesterol, mmol L−1 6.5 ± 1.2 6.9 ± 1.3∗
Total calcium, mmol L−1 2.37 ± 0.10 2.38 ± 0.11
Mean IMT, mm 0.90 ± 0.20 0.84 ± 0.17∗∗
TPA†, mm2 12.1 ± 19.4 7.6 ± 13.0





samplingwere included in the respective regressionmodels as
covariates. Since men and women have significantly different
mean IMT, genders were analysed separately. Comparisons
between groups were analysed with ANOVA.The analysis of
the whole population was performed without the exclusion
of smokers. We have identified 5 groups of 25(OH)D concen-
tration (<30.0 nmol/L, 30.0–49.9 nmol/L, 50.0–74.9 nmol/L,
75.0–100.0 nmol/L, and >100.0 nmol/L). Using the cutoff of
the highest mean IMT quartile as a clinical endpoint and
the 25(OH)D groups as predictors, the logistic regression
was applied, adjusted for age, BMI, SBP, season for vitamin
D sampling, total cholesterol, and smoking status. All tests
were done two sided, and a 𝑃 value < 0.05 was considered
statistically significant.The data was analysed with IBM SPSS
Statistics Version 19 (SPSS Inc., Chicago, IL, USA).
2.5. Ethics. The study was approved by the Regional Com-
mittee for Medical and Health Research Ethics, the Data
Inspectorate, and the Norwegian Directorate of Health.
2.6. Results. Ultrasound examination of the right carotid
artery was performed in 6727 subjects (77% of the eligible)
and in 6230 of those serum 25(OH)D measurements were
available. After smokers were excluded, 1994 men and 2200
women were included in the final analysis.
The characteristics of the study population are shown in
Table 1.
There were no linear associations between serum
25(OH)D and either mean IMT or TPA, when adjusted
for age, BMI, systolic blood pressure, total cholesterol, and
season of blood sampling (Tables 2 and 3). To study the
threshold effects, we compared the ORs, across quartiles of
IMT and tertiles of TPA, with the lowest quartile of IMT
and the no plaque group as reference groups, respectively. In
males, a 1 SD increase in serum 25(OH)Dwas associated with
a 30% increased odds for having IMT >1.00mm, compared
to the reference group (Table 4). No effect of serum 25(OH)D
was found on TPA. In females, no independent association
was found between serum 25(OH)D and mean IMT.
However, a 1 SD increase in serum 25(OH)D was associated
with a 15% higher odds of having TPA >18.07mm2 versus
the absence of plaques (Table 4).
In crude analyses, the increase in total calcium was
associated with the increased odds being in higher levels of
mean IMT and TPA (Table 5). When adjusted for age, BMI,
SBP, and total cholesterol, neither of these associations was
significant (Table 5).
The logistic regression analysis with 25(OH)D groups as
the predictor variable and the sex-specified highest quartile
of mean IMT as an outcome variable was performed in the
whole population, without the exclusion of smokers as well
as in nonsmokers. Neither of the 25(OH)D groups turned out
to be a significant predictor of the highest quartile of mean
IMT in both genders in the whole population, whereas male
nonsmokers with serum 25(OH)D >100 nmol/L were at 77%
higher risk to have mean IMT >1.00mm, compared to those
with serum 25(OH)D within the range 75–100 nmol/L, but
not statistically significant, Table 6.
3. Discussion
In our large subgroup of non-smoking general population,
men had a significantly higher mean IMT compared to
women. Impaired calcium homeostasis was not found to
have a significant association with mean IMT and TPA. An
increase in serum 25(OH)D was independently associated
with increased odds of being in the highest quartile of mean
IMT >1.00mm in males and TPA >18.07mm2 in females.
No associations were observed between total calcium and
mean IMT or TPA. When smokers were included in our
cohort, serum 25(OH)Dwas no longer a significant predictor
of higher mean IMT in either gender.
Male gender, increased BMI, and smoking status are
well-established risk factors of carotid stenosis (1,2), and
our finding of higher IMT in men supports the results in
other studies [18]. Recently, a significant contributing impact
of deranged calcium homeostasis with decreased serum
25(OH)D and high calcium-phosphorus product has been
reported in the observational studies [6, 11]. There is also
some evidence that the active vitamin D metabolite, 1,25
dihydroxyvitamin D (1,25(OH)
2
D), might exert beneficial
physiological effects in both vascular smooth muscle cells
and the vascular endothelium [19]. In an observational study
by Al Mheid et al. [20] on 554 healthy volunteers, lower
levels of serum 25(OH)D were associated with vascular stiff-
ness and endothelial function. However, to our knowledge,
none of the randomised trials have supported any causal
association between vitamin D and arterial disease. In a
study by Stricker et al. [21], 62 patients with peripheral
artery disease without vitamin D deficiency received either
a single dose of 100,000 IU cholecalciferol or placebo in an
observation period of 1 month. No influence of vitamin D
supplementation was demonstrated on either cardiovascular
surrogate parameters (blood pressure, aortic stiffness, and
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Table 2: Serum25(OH)D (means± SD) in quartiles ofmean IMT inmen and regression coefficients (𝛽)with their respective 95% confidential
intervals from linear regression models. The 4th Tromsø Study, 1994-1995.
Mean IMT quartiles, mm (𝑁) Serum 25(OH)D¶, nmol L−1 Total calcium, mmol L−1
Men, 𝑛 = 1994
<0.76 (500) 53.7 ± 16.1 2.38 ± 0.10
0.76–0.87 (498) 55.5 ± 16.8 2.37 ± 0.10
0.88–1.00 (495) 54.2 ± 16.4 2.37 ± 0.10
>1.00 (501) 56.0 ± 17.2 2.36 ± 0.11
𝑃 for trend NS NS
𝛽 unadjusted (95% CI)₤ 0.04 (−0.01, 0.09) −0.03 (−0.08, 0.02)
𝛽 adjusted† (95% CI)₤ 0.05 (0.00, 0.01) −0.10 (−0.05, 0.03)
Women, 𝑛 = 2200
<0.72 (554) 51.9 ± 18.0 2.36 ± 0.11
0.72–0.81 (547) 50.1 ± 17.0 2.38 ± 0.12
0.82–0.93 (548) 50.0 ± 16.0 2.39 ± 0.11
>0.93 (551) 47.9 ± 16.7 2.40 ± 0.11
𝑃 for trend <0.001 <0.001
𝛽 unadjusted (95% CI)₤ −0.08 (−0.14, −0.05) 0.12 (0.08, 0.17)∗
𝛽 adjusted† (95% CI)₤ 0.02 (−0.02, 0.06) 0.21 (−0.02, 0.06)
¶Adjusted for season of blood testing.
∗
𝑃 < 0.01.
₤Mean IMT as the dependent variable in the linear regression model.
†Adjusted for age, BMI, systolic blood pressure, and total cholesterol.
Table 3: Serum 25(OH)D (means ± SD) in the TPA groups in men and women and regression coefficients (𝛽) with their respective 95%
confidential intervals from linear regression models. The 4th Tromsø Study, 1994-1995.
TPA groups, mm2(𝑁) Serum 25(OH)D¶, nmol L−1 Total calcium, mmol L−1
Men, 𝑛 = 1994
No plaques (949) 54.0 ± 16.4 2.37 ± 0.10
<11.37 (348) 55.7 ± 17.0 2.37 ± 0.10
11.37–23.89 (347) 55.6 ± 16.6 2.36 ± 0.10
>23.89 (348) 54.9 ± 16.9 2.37 ± 0.11
𝑃 for trend NS NS
𝛽 unadjusted (95% CI)₤ 0.02 (−0.03, 0.07) −0.03 (−0.08, 0.02)
𝛽 adjusted† (95% CI)₤ 0.02 (−0.03, 0.06) −0.03 (−0.08, 0.01)
Women, 𝑛 = 2200
No plaques (1238) 50.3 ± 16.3 2.37 ± 0.11
<9.42 (319) 49.5 ± 18.3 2.38 ± 0.12
9.42–18.07 (321) 50.2 ± 17.7 2.39 ± 0.12
>18.07 (322) 48.6 ± 16.0 2.40 ± 0.11
𝑃 for trend NS <0.001
𝛽 unadjusted (95% CI)₤ −0.03 (−0.07, 0.02) 0.08 (0.04, 0.13)∗
𝛽 adjusted† (95% CI)₤ 0.04 (−0.01, 0.08) 0.01 (−0.04, 0.05)
¶Adjusted for season of blood testing.
∗
𝑃 < 0.05.
₤Square root transformed TPA as the dependent variable in the linear regression model.
†Adjusted for age, BMI, systolic blood pressure, and total cholesterol.
endothelial function) or parameters of thrombosis (markers
of thrombin generation and markers for fibrinolysis and
platelet activation). We have previously reported an associa-
tion between the thrombogram parameters and serum levels
of 25(OH)D [22]. However, similarly to the study by Stricker
et al. [21], no influence of vitamin D supplementation on
those parameters was seen.
Inconsistent results on vitamin D and peripheral
atherosclerosis burden were also demonstrated in the disease
state. Thus, in 390 diabetic patients, the hypovitaminosis
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Table 4: Odds ratios (OR) and their respective 95% confidential intervals for the association between serum 25(OH)D and levels of mean
IMT and TPA in men and women, using multinomial logistic regression. The 4th Tromsø Study, 1994-1995.
Multivariate
models
Men, 𝑛 = 1994
Mean IMT quartiles, mm TPA groups, mm2
<0.76 0.76–0.87 0.88–1.00 >1.00 No plaques <11.37 11.37–23.89 >23.89
Model 1 1.00 1.11 (0.98, 1.26) 1.03 (0.90, 1.17) 1.14∗ (1.00, 1.30) 1.00 1.09 (0.96, 1.23) 1.09 (0.97, 1.24) 1.03 (0.91, 1.17)
Model 2 1.00 1.14 (0.99, 1.30) 1.12 (0.96, 1.30) 1.30∗∗ (1.12, 1.51) 1.00 1.06 (0.93, 1.20) 1.10 (0.96, 1.25) 1.08 (0.94, 1.23)
Multivariate
models
Women, 𝑛 = 2200
Mean IMT quartiles, mm TPA groups, mm2
<0.72 0.72–0.81 0.82–0.93 >0.93 No plaques <9.42 9.42–18.07 >18.07
Model 1 1.00 0.90 (0.80, 1.01) 0.89 (0.80, 1.01) 0.77 (0.68, 0.86)∗∗ 1.00 0.93 (0.82, 1.06) 0.98 (0.87, 1.11) 0.89 (0.78, 1.01)
Model 2 1.00 1.02 (0.90, 1.16) 1.12 (0.98, 1.28) 1.10 (0.96, 1.28) 1.00 1.00 (0.88, 1.14) 1.12 (0.98, 1.27) 1.15∗ (1.01, 1.33)
Model 1. Serum 25 (OH) D adjusted for season when vitamin D samples were obtained.





Table 5: Odds ratios (OR) and their respective 95% confidential intervals for the association between total calcium and levels of mean IMT
and TPA in men and women, using multinomial logistic regression. The 4th Tromsø Study, 1994-1995.
Multivariate
models
Men, 𝑛 = 1994
Mean IMT quartiles, mm TPA groups, mm2
<0.76 0.76–0.87 0.88–1.00 >1.00 No plaques <11.37 11.37–23.89 >23.89
Model 1 1.00 0.92 (0.81, 1.03) 0.95 (0.84, 1.07) 0.91 (0.81, 1.03) 1.00 0.92 (0.82, 1.04) 0.88∗ (0.78, 1.00) 0.96 (0.85, 1.08)
Model 2 1.00 1.01 (0.88, 1.16) 1.04 (0.90, 1.19) 0.95 (0.82, 1.10) 1.00 0.93 (0.82, 1.05) 0.87 (0.77, 0.99) 0.92 (0.81, 1.05)
Multivariate
models
Women, 𝑛 = 2200
Mean IMT quartiles, mm TPA groups, mm2
<0.72 0.72–0.81 0.82–0.93 >0.93 No plaques <9.42 9.42–18.07 >18.07
Model 1 1.00 1.17∗∗ (1.04, 1.31) 1.27∗∗∗ (1.13, 1.43) 1.38∗∗∗ (1.23, 1.55) 1.00 1.02 (0.90, 1.14) 1.12∗ (1.00, 1.27) 1.24∗∗∗ (1.10, 1.40)
Model 2 1.00 1.03 (0.90, 1.16) 1.08 (0.94, 1.23) 1.08 (0.94, 1.24) 1.00 0.92 (0.81, 1.05) 0.99 (0.87, 1.12) 1.03 (0.90, 1.17)
Model 1. Total calcium, unadjusted.







D (defined as serum 25(OH)D <15 nmol/L) was associated
with greater IMT [23]. Whereas, in a study by Yiu et al. [24],
daily oral supplementation of 5000 IU vitamin D3 was given
to 100 patients with type II diabetes during a 12-week period,
and no improvement in vascular function was seen at the
end of the study.
Our study is, to our knowledge, the largest observational
study on the associations between serum 25(OH)D and
markers of carotid atherosclerosis. No convincing associa-
tions were observed between serum 25(OH)D and intima-
media thickness or plaques in a large subgroup of nonsmok-
ers.The findings are consistent with other recent reports [25–
27].
However, there is accumulating evidence that insufficient
vitamin D status has adverse effects on the metabolic profile
[13] andmay be associated with the severity of arterial disease
[28]. The potential role of vitamin D in atherogenesis, if any,
is not completely known. It has also been speculated that
vitamin D may possess some antithrombotic propensities
[29], although no effects of vitamin D supplements were
found on the markers of thrombosis [21, 22]. In animal
models, oral supplementation with vitamin D reduced the
formation of atherosclerotic plaques by the suppression of
T lymphocytes [30]. Moreover, in a study by Pilz et al.
[31], low serum 25(OH)D and 1,25(OH)
2
Dwere independent
predictors of fatal stroke in more than 3000 subjects who
were routinely referred to coronary angiography. It is hard
to find an explanation for such discrepant findings. One
of the possible explanations may be the existence of strong
confounders that could either distort the association between
vitamin D and atherosclerosis towards or away from the null
hypothesis [32]. Smoking status and total calcium might be
considered as some of these confounders. Alternatively, in
studies where the regression analysis is adjusted for smoking
status, smoking could still be the nuisance variable that
distorts the association between exposure (serum 25(OH)D
levels) and outcome (increased IMT and/or plaques) and
either magnifies or decreases the statistical associations. In
6 International Journal of Endocrinology
Table 6: Adjusted odds ratio (OR) and their respective 95% confidential intervals for IMT >1.00 mm in men and IMT >0.93 mm in women





𝑛 Men 𝑛 Women 𝑛 Men 𝑛 Women
<30.0 94 0.63 (0.36, 1.12) 226 1.01 (0.65, 1.55) 78 0.64 (0.32, 1.31) 204 0.59 (0.33, 1.05)
30.0–49.9 853 0.67 (0.51, 0.89) 1101 1.10 (0.81, 1.52) 742 0.72 (0.48, 1.08) 975 0.71 (0.44, 1.16)
50.0–74.9 1466 0.81 (0.64, 1.03) 1353 1.07 (0.80, 1.43) 963 0.92 (0.62, 1.36) 878 0.71 (0.43, 1.16)
75.0–100.0 484 1.0 (Reference) 456 1.0 (Reference) 185 1.0 (Reference) 126 1.0 (Reference)
>100.0 99 0.90 (0.54, 1.49) 98 0.74 (0.40, 1.38) 26 1.77 (0.62, 4.81) 17 0.22 (0.03, 1.85)
∗Adjusted for age, BMI, SBP, season for vitamin D sampling, total cholesterol, and smoking status.
¶Adjusted age, BMI, SBP, season for vitamin D sampling, and total cholesterol.
our study, we excluded all smokers and created separate
statistical models for vitamin D and total calcium, thus
combating powerful confounders.
Our findings of possible harmful effects of vitamin D
on IMT and plaques in general non-smoking population are
to our knowledge novel. Even though the findings should
be interpreted with caution, a significant 30% higher risk
of having mean IMT in the fourth quartile versus first
quartile per 1 SD increase in 25(OH)D in males is hard
to ignore. Moreover, the serum 25(OH)D concentrations
>100.0 nmol/L might be potentially harmful towards the
mean thickness of intima media in non-smoking males.
Noteworthy, Zittermann et al. [33] reported a significant
adverse effect of an increased serum 25(OH)D (>100 nmol/L)
in a selected group of patients, undergoing heart surgery.
The authors have demonstrated the U-shaped unadjusted
association between preoperatively measured 25(OH)D and
composite adverse outcome in patients scheduled for cardiac
surgery. This recent finding and our results of a possible
harmful impact of increased 25(OH)D definitely require
further investigations and confirmative studies.
Our study has several limitations. First of all, smoking
status was self-reported; thus biased self-reporting could
have affected the inclusion cohort. Secondly, we mea-
sured IMT and plaques only in the right carotid artery,
whereas measurements in both carotid arteries might have
been more representative. And finally, we did not have
the opportunity to adjust for serum parathyroid hormone
(PTH), vitamin D binding protein (DBP), and circulating
1,25(OH)
2
D since the measurements of serum PTH were
not available for the majority of our study participants and
we did not measure DBP in our study. Another major
shortcoming is that we were unable to measure the circu-
lating 1,25(OH)
2
D levels, as in previous studies an inverse
association between 1,25(OH)
2
D and coronary calcification
was demonstrated [34]. On the other hand, we did include
a substantial amount of subjects, and we included the
analysis of total calcium and eliminated the major con-
founder smoking. We also adjusted the measurements for
age, BMI, and total cholesterol, and the results of our large
cross-sectional study are confirmative to previous reports
[25–27].
4. Conclusions
In conclusion, we demonstrated no consistent association
between serum 25(OH)D and mean IMT and TPA in a large
group of non-smokingmen andwomen.However, increment
in serum 25(OH)D was associated with the elevated risk of
being in the highest quartile of mean IMT in males and of
having the largest TPA in women in our fairly vitamin D
sufficient population. The clinical impact of vitamin D status
for carotid artery disease prevention is most likely scanty,
and potential clinical trials on subjects without vitamin D
deficiency should be performed with caution.
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